AIDSinfo At-a-Glance

Issue No. 43

December 8, 2005 

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.    

 

 

FDA’s CCR5 Antagonist Meeting Postponed

The FDA has postponed the CCR5 Antagonist Review Group and the Forum for Collaborative HIV Research meeting until early 2006.

The original meeting, scheduled for January 18, 2006, was planned to address long-term clinical trial follow-up issues in a timely manner. However, because additional trial data will be available soon, the meeting will be pushed back to ensure that the public discussion is as effective as possible.

The FDA will send out an announcement once the new meeting date is set.
For more information, go to http://www.hivforum.org/CCR5/index.html.

 

 

NIDA HIV/AIDS Page for Teens

The National Institute on Drug Abuse (NIDA) has dedicated a portion of the NIDA for Teens Web site to HIV/AIDS and its implications for young people. According to the CDC, over 38,000 young people age 13 to 24 were diagnosed with AIDS in the United States by the end of 2003. The NIDA for Teens pages on HIV/AIDS gives youths important information about how drug abuse and HIV are related, how teens are affected by HIV, how teens can protect themselves against HIV infection, and a section called “Ask Dr. NIDA: HIV, AIDS, and Drug Abuse.” Check out the NIDA for Teens HIV/AIDS page here.

 

 

Tenth Anniversary of Protease Inhibitors

The first protease inhibitor was approved ten years ago this week, establishing a new class of antiretroviral drug and ushering in a new era of treatment for HIV infection. In December 1995, the approval of using protease inhibitor drugs in combination with other antiretroviral drugs was revolutionary. The availability of protease inhibitors raised treatment standards, significantly improving the lives and health of people living with HIV in the United States and around the world. To learn more about treatment options for HIV/AIDS, check out the  AIDSinfo fact sheet booklet “HIV/AIDS and Its Treatment: What You Should Know” .

 

 

AIDSinfo Live Help

AIDSinfo Live Help provides confidential, one-on-one online assistance to help you:

1. Navigate the AIDSinfo Web site
2. Find answers to your questions about federally approved information on HIV/AIDS treatment, HIV/AIDS clinical trials, HIV vaccines, and treatment and prevention guidelines

AIDSinfo Live Help has trained health information specialists available to assist you in English or Español, Monday—Friday, 12:00 p.m.—4:00 p.m. Eastern Time at Live Help, or call our toll free number: 1-800-448-0440. International callers: 301-519-0459, Fax: 301-519-6616, TTY/TDD: 1-888-480-3739, or e-mail: ContactUs@aidsinfo.nih.gov.

 

 

ClinicalTrials.gov Info

Please send comments or suggestions to ContactUs@aidsinfo.nih.gov

You are currently subscribed to %%list.name%% as: %%emailaddr%%
To unsubscribe send a blank email to: leave-aidsinfo_e_news-1394849V@listmanager.aspensys.com

Subscribe to AIDSinfo list serv here.

Contact AIDSinfo

Click on the Live Help button on the AIDSinfo home page and communicate with the staff in “real time.”
-or-
Telephone: 800-448-0440
International Telephone: 301-519-0459
TTY/TDD: 888-480-3739
Fax: 301-519-6616
E-mail: ContactUs@aidsinfo.nih.gov

Download Adobe Acrobat® Reader™ to view PDF files located on this site.